Kimberly-Clark Worldwide, Inc.
USPTO PatentsView assignee record - 1,135 granted patents across 143 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Kimberly-clark ranks #391 of 49,997 tracked US assignees by granted-patent volume, with 1,135 patents across 143 technology areas.
- #391
- of 49,997 US assignees by volume
- Top 2%
- by Innovation Score (63.6/100)
- 14.2
- avg claims per patent
- -19%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R391 · US Corporation #391 · 1,135 grants
GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-LARGE 1.1K grants
- TOP-DECILE #391/49,997
- PHOTO-FINISH Taiyo Yuden
- CPC-WIDE A61F · 143 areas
- INNOV-STRONG 63.6/100
- CLAIMS-RICH 14.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -19% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Taiyo Yuden Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Kimberly-clark’s 63.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Kimberly-clark
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Assa Abloy AB · near
Assa Abloy AB · near
64 score
- Boehringer Ingelheim… · near
Boehringer Ingelheim… · near
64 score
- Kimberly-Clark… · this assignee
Kimberly-Clark… · this assignee
64 score
- Maxell · near
Maxell · near
64 score
- Yeda Research AND… · near
Yeda Research AND… · near
64 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Kimberly-clark's Innovation Score is 63.6/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Kimberly-clark?
Each dot is one of Kimberly-clark’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kimberly-clark’s own 14.2 claims/patent is ABOVE the 11.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
How Kimberly-clark's grant cadence moved
Between 2020–2024, Kimberly-Clark Worldwide, Inc. received 471 grants versus 584 in 2015–2019 (-19% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 156 grants and bottomed in 2024 at 84. Lead class A61F accounts for 37.6% of the portfolio across 143 subclasses. Volume neighbours: Northrop Grumman Systems Corporation (#387) and Toshiba Medical Systems Corporation (#395).
Kimberly-clark's three-year grant acceleration
From 2019–2021 to 2022–2024, Kimberly-Clark Worldwide, Inc. moved from 312 to 270 grants (0.86x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,611. See the growth leaderboard.
Who files at Kimberly-Clark's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Northrop Grumman…
Northrop Grumman Systems Corporation
1,140 patents
- Cadence Design Sy…
Cadence Design Systems, Inc.
1,138 patents
- Aisin Seiki
Aisin Seiki Kabushiki Kaisha
1,137 patents
- Korea Institute O…
Korea Institute OF Science AND Technology
1,136 patents
- Taiyo Yuden
Taiyo Yuden Co., Ltd.
1,135 patents
- Kimberly-clark Wo… ◀
Kimberly-Clark Worldwide, Inc.
1,135 patents
- Orange
Orange
1,134 patents
- Molex
Molex, LLC
1,132 patents
- Toshiba Medical S…
Toshiba Medical Systems Corporation
1,132 patents
What this shows Kimberly-Clark holds 1,135 patents at rank #391, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Kimberly-Clark
By rank, the assignees closest to #391 in granted patent volume.
- Northrop Grumman Systems Corporation #387 · 1,140 patents
- Cadence Design Systems, Inc. #388 · 1,138 patents
- Aisin Seiki Kabushiki Kaisha #389 · 1,137 patents
- Korea Institute OF Science AND Technology #390 · 1,136 patents
- Taiyo Yuden Co., Ltd. #392 · 1,135 patents
- Orange #393 · 1,134 patents
- Molex, LLC #394 · 1,132 patents
- Toshiba Medical Systems Corporation #395 · 1,132 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Kimberly-Clark's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Kimberly-Clark, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Kimberly-Clark ranks #10 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (64 here).
Similar claim depth
Nearest assignees by average claims per patent (14.2 here).
Kimberly-clark's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
64 Top 2% higher than 98% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 116 | 10.2% |
| 2016 | 156 | 13.7% |
| 2017 | 102 | 9.0% |
| 2018 | 99 | 8.7% |
| 2019 | 111 | 9.8% |
| 2020 | 110 | 9.7% |
| 2021 | 91 | 8.0% |
| 2022 | 91 | 8.0% |
| 2023 | 95 | 8.4% |
| 2024 | 84 | 7.4% |
| 2025partial year | 80 | 7.0% |
Which technologies does Kimberly-Clark Worldwide, Inc. patent most?
Top 15 of 143 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Kimberly-Clark Worldwide, Inc.'s patent record in context - here's where to go next.
- Kimberly-Clark Worldwide, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 37.6% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #391 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Kimberly-Clark Worldwide, Inc. against Northrop Grumman Systems Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 63.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.